Galectin Therapeutics Inc (GALT)

0.87 +0.03 (+3.50%) USD  |  NASDAQ  |  Dec 26, 13:54
More

Galectin Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Alaunos Therapeutics Inc Upgrade
SELLAS Life Sciences Group Inc Upgrade
Oragenics Inc Upgrade
Anavex Life Sciences Corp Upgrade
Phathom Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade